Harel Shiraz, Lukasik James, Wilcox Annabelle, Lipska Kasia J, Weinzimer Stuart A, Suttiratana Sakinah C, Nally Laura M
Department of Pediatrics, Yale School of Medicine, New Haven, CT, United States.
Department of Psychiatry, Stanford University, Stanford, CA, United States.
Front Endocrinol (Lausanne). 2025 Mar 24;16:1555265. doi: 10.3389/fendo.2025.1555265. eCollection 2025.
People with diabetes (PWD) face significant barriers to accessing insulin and diabetes supplies, including high prices, leading some to turn to social media for material support. This study explores emotions among PWD who have relied on assistance from social media networks when navigating access to diabetes medications and supplies (DMS).
We conducted a mixed methods study of individuals with type 1 diabetes (T1D) and their caregivers who have used social media to obtain DMS. Participants were recruited through social media based on self-reported use of social media to obtain diabetes support. Transcripts of semi-structured, telephone interviews were analyzed and categorized, and consensus discussions resolved discrepancies and refined definitions of themes.
Thirty individuals (mean age 31+/- 8 years, 29 female, 5 caregivers) were interviewed. The analysis revealed four categories of emotions: anxiety and stress, fear of health problems and financial consequences, frustration with the healthcare system, and feelings of powerlessness and vulnerability. Nearly all interviewees reported anxiety or stress due to the financial burden of managing diabetes and fear for their or their child's health and safety. Diabetic ketoacidosis, unnecessary bodily harm or sickness, or fear of dying due to running out of insulin worried participants. Most participants described the process of obtaining DMS to be more stressful than their daily diabetes management.
PWD described strong negative emotions related to navigating the healthcare system and acquiring DMS. Policy changes are urgently needed to support to individuals with type 1 diabetes in order to enhance their quality of life, guarantee equitable access to care, and cultivate a more compassionate and inclusive healthcare system. The reported magnitude of stress is notable, especially given the attention typically focused on the stress of diabetes management.
糖尿病患者在获取胰岛素和糖尿病用品方面面临重大障碍,包括价格高昂,这导致一些人转向社交媒体寻求物质支持。本研究探讨了在获取糖尿病药物和用品(DMS)过程中依赖社交媒体网络援助的糖尿病患者的情绪。
我们对使用社交媒体获取DMS的1型糖尿病(T1D)患者及其护理人员进行了一项混合方法研究。根据自我报告使用社交媒体获取糖尿病支持的情况,通过社交媒体招募参与者。对半结构化电话访谈的记录进行分析和分类,并通过共识讨论解决差异并完善主题定义。
共访谈了30人(平均年龄31±8岁,29名女性,5名护理人员)。分析揭示了四类情绪:焦虑和压力、对健康问题和经济后果的恐惧、对医疗系统的沮丧以及无力感和脆弱感。几乎所有受访者都表示,由于管理糖尿病的经济负担以及对自己或孩子健康与安全的担忧而感到焦虑或压力。糖尿病酮症酸中毒、不必要的身体伤害或疾病,或因胰岛素用完而害怕死亡让参与者忧心忡忡。大多数参与者表示,获取DMS的过程比日常糖尿病管理更具压力。
糖尿病患者描述了在应对医疗系统和获取DMS方面强烈的负面情绪。迫切需要政策变革来支持1型糖尿病患者,以提高他们的生活质量,确保公平获得医疗服务,并建立一个更具同情心和包容性的医疗系统。所报告的压力程度值得关注,尤其是考虑到通常对糖尿病管理压力的关注。